Alyeska Investment Group’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-150,000
| Closed | -$1.52M | – | 560 |
|
|
2022
Q4 | $1.52M | Hold |
150,000
| – | – | 0.02% | 335 |
|
|
2022
Q3 | $1.49M | Hold |
150,000
| – | – | 0.02% | 329 |
|
|
2022
Q2 | $1.47M | Hold |
150,000
| – | – | 0.02% | 441 |
|
|
2022
Q1 | $1.46M | Hold |
150,000
| – | – | 0.02% | 469 |
|
|
2021
Q4 | $1.45M | Hold |
150,000
| – | – | 0.02% | 488 |
|
|
2021
Q3 | $1.45M | Hold |
150,000
| – | – | 0.02% | 555 |
|
|
2021
Q2 | $1.46M | Buy |
+150,000
| New | +$1.46M | 0.02% | 550 |
|